Association of Genetic Variation in Calmodulin and Left Ventricular Mass in Full-Term Newborns

Table 2

Overview of results depending on fetal genotypes.

	GG; 𝑛=69	GA; 𝑛=95	AA; 𝑛=42	P
Gender M/F	42/47 (37%/29%)	53/42 (46%/46%)	19/23 (17%/25%)	0.273
Gestational age (weeks)	39.3±0.9	39.5±1.0	39.0±1.0	0.019
Birth weight (kg)	3.48±0.46	3.5±0.43	3.4±0.47	0.503
Neonatal body length (cm)	0.56±0.03	0.56±0.03	0.55±0.03	0.384
Neonatal head circumference (cm)	33.9±1.5	33.7±1.3	34.1±1.3	0.633
Apgar 3 min	9.7±0.9	9.6±0.8	9.5±1.3	0.734
SBP (mmHg )	68.7±8.0	68.8±9.1	70.4±10.4	0.574
SBP ≥ 90 percentile n, (%)	4 (40,0)	9 (45,0)	7 (35,0)	0.173
DBP (mmHg)	39.5±7.4	40.0±7.4	41.0±9.5	0.634
DBP ≥ 90 percentile	5 (23.8)	7 (33.3)	9 (42.9)	0.027
MAP (mmHg)	51.5±7.1	52.0±6.9	52.4±9.9	0.830
MAP ≥ 90 percentile	6 (27.27)	9 (40.91)	7 (31.82)	0.373
Maternal age (years)	28.2±6.0	27.7±5.2	29.3±4.5	0.274
Smoking habits; History during pregnancy n, (%)	7 (33.33)	11 (52.38)	3 (14.29)	0.731
Hypertension; History during pregnancy or; history of hypertension n, (%)	3 (17.65)	8 (47.06)	6 (35.29)	0.182
BMI (kg/m^2) at the beginning of pregnancy	21.7±2.9	22.2±3.6	22.9±4.7	0.251
BMI (kg/m^2) at the end of pregnancy	27.3±3.6	28.0±4.0	27.7±4.6	0.539
Parity	1.6±08	1.4±0.8	1.6±0.9	0.292